| 1 |
21680782 | A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology. | 2012 Jun |
1 |
| 2 |
22191463 | Pulmonary administration of interferon Beta-1a-fc fusion protein in non-human primates using an immunoglobulin transport pathway. | 2012 Apr |
1 |
| 3 |
21690216 | In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1a. | 2011 Sep |
2 |
| 4 |
20639271 | Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis. | 2010 Sep |
1 |
| 5 |
19054274 | Pharmacokinetics and pharmacodynamics of interferon beta 1a in Cebus apella. | 2009 Jun |
2 |
| 6 |
17101906 | Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS. | 2006 Nov 14 |
1 |
| 7 |
16339068 | Gamma interferon is dispensable for neopterin production in vivo. | 2005 Dec |
1 |
| 8 |
14653852 | Is serum neopterin level a marker of responsiveness to interferon beta-1a therapy in multiple sclerosis? | 2004 Jan |
2 |
| 9 |
12011292 | A one-year study on the pharmacodynamic profile of interferon-beta1a in MS. | 2002 May 14 |
1 |
| 10 |
12425473 | Receptor-mediated pharmacokinetic/pharmacodynamic model of interferon-beta 1a in humans. | 2002 Oct |
1 |
| 11 |
12488496 | Monocyte-derived dendritic cells release neopterin. | 2002 Dec |
1 |
| 12 |
9595973 | Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) | 1998 May |
1 |
| 13 |
8483840 | Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin. | 1993 Apr |
1 |
| 14 |
1431312 | Double-blind randomized phase I study on the clinical tolerance and biological effects of natural and recombinant interferon-beta. | 1992 Oct |
3 |
| 15 |
1591013 | Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide. | 1992 Jun |
1 |
| 16 |
2120284 | A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans. | 1990 Oct |
1 |
| 17 |
2129033 | Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma. | 1990 Sep-Oct |
2 |
| 18 |
3068316 | Biochemical host response to interferon-beta. | 1988 Dec |
1 |